QLC5508 in Participants With Metastatic Prostate Cancer

Clinical trial NCT07632690 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07632690
Sponsor: Qilu Pharmaceutical Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2026-06-20
Primary completion: 2028-06-20
Enrollment: 700

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.